Clinical burden of autosomal dominant polycystic kidney disease

There are no specific therapies for autosomal dominant polycystic kidney disease (ADPKD), and clinical data evaluating the effects of non-specific therapies on ADPKD patients are scarce. We therefore evaluated those effects using data from a longitudinal health insurance database collected from 2000...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Peir-Haur, Lin, Chien-Hung, Hung, Kuan-Yu, Muo, Chih-Hsin, Chung, Mu-Chi, Chang, Chao-Hsiang, Chung, Chi-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066921/
https://www.ncbi.nlm.nih.gov/pubmed/32096480
http://dx.doi.org/10.18632/aging.102858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066921/
https://www.ncbi.nlm.nih.gov/pubmed/32096480
http://dx.doi.org/10.18632/aging.102858

Ejemplares similares